Standout Papers
- Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial (2016)
- PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer (2017)
- Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer (2018)
Immediate Impact
1 by Nobel laureates 14 from Science/Nature 62 standout
Citing Papers
The dawn of spatial omics
2023 StandoutScience
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
2023 Standout
Works of Jonathan Juco being referenced
Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer
2018 Standout
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
2016 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jonathan Juco | 1848 | 1007 | 368 | 725 | 23 | 2.5k | |
| Kumudu Pathiraja | 2593 | 1119 | 290 | 564 | 36 | 3.3k | |
| Marina Tschaika | 1617 | 661 | 212 | 653 | 37 | 2.2k | |
| Robert Ford | 2090 | 1387 | 255 | 593 | 19 | 3.6k | |
| Christian Meyer zum Büschenfelde | 1385 | 1031 | 154 | 719 | 31 | 2.4k | |
| J.H.J.M. van Krieken | 1511 | 1312 | 466 | 1005 | 34 | 3.4k | |
| Joseph L. Leach | 1998 | 562 | 818 | 723 | 38 | 2.8k | |
| Tianhua Guo | 910 | 1551 | 210 | 525 | 14 | 2.7k | |
| Akin Atmaca | 2103 | 1380 | 195 | 553 | 60 | 3.2k | |
| Gregg Fine | 2744 | 885 | 426 | 802 | 32 | 3.7k | |
| Bryan Goldman | 1257 | 1631 | 307 | 953 | 64 | 3.4k |
All Works
Loading papers...